4.5 Review

Minireview: 3-Iodothyronamine (T(1)AM): A New Player on the Thyroid Endocrine Team?

期刊

ENDOCRINOLOGY
卷 150, 期 3, 页码 1108-1111

出版社

ENDOCRINE SOC
DOI: 10.1210/en.2008-1596

关键词

-

资金

  1. National Institutes of Health [DK-52798]
  2. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052798, R01DK052798] Funding Source: NIH RePORTER

向作者/读者索取更多资源

3-Iodothyronamine (T(1)AM) is an endogenous compound with chemical features that are similar to thyroid hormone. T(1)AM has a carbon skeleton identical to that of T-4 and contains a single carbon-iodine bond. Theoretically, T(1)AM could be produced from T-4 by enzymatic decarboxylation and deiodination. Recent studies show that T(1)AM and higher iodinated thyronamines are subject to similar metabolic processing as iodothyronines such as T-4, suggesting a biological linkage between iodothyronines and iodothyronamines. In addition, single doses of T(1)AM administered to rodents induce a hypometabolic state that in certain ways resembles hibernation and is opposite to the effects of excess T-4. This review will discuss the latest developments on this recently discovered thyroid hormone derivative. (Endocrinology 150: 1108-1111, 2009)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据